Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.53M Buy
8,899
+632
+8% +$286K 0.04% 276
2025
Q4
$3.92M Sell
8,267
-2,099
-20% -$932K 0.05% 237
2025
Q3
$5.11M Buy
10,366
+6,972
+205% +$3.94M 0.07% 201
2025
Q2
$1.74M Sell
3,394
-950
-22% -$443K 0.02% 406
2025
Q1
$1.86M Buy
4,344
+262
+6% +$127K 0.03% 351
2024
Q4
$1.99M Sell
4,082
-411
-9% -$215K 0.03% 353
2024
Q3
$2.23M Buy
4,493
+463
+11% +$248K 0.03% 327
2024
Q2
$2.42M Buy
+4,030
New +$2.28M 0.04% 275

Other funds holding SNPS

Choreo LLC's SNPS Position: Q1 2026 in Review

Choreo LLC increased its Synopsys (SNPS) stake by 7.6% in Q1 2026, buying an estimated $286K and bringing the position to 8,899 shares worth $3.53M. The position accounts for 0.04% of the portfolio, ranked #276.

Choreo LLC first reported a position in SNPS in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.11M in Q3 2025. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Choreo LLC held 8,899 shares of Synopsys worth $3.53M as of Q1 2026.
  • Choreo LLC bought 632 Synopsys shares in Q1 2026, an estimated $286K.
  • Synopsys made up 0.04% of Choreo LLC's portfolio in Q1 2026, its #276 holding.
  • Choreo LLC first reported a position in Synopsys in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's Synopsys position peaked at $5.11M in Q3 2025.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.